Company profile
Zimmer Biomet Holdings, Inc.
NYSE: ZBH · Healthcare · Medical - Devices
#46 of 1,418 Healthcare companies by revenue52nd-percentile growth
EA Score
80B+FH 83DQ 81GM 64SS 92
v0.1 · 65/100 weight · provisional
↑ Piotroski F, market scale · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$8.4B
Rev growth YoY (TTM)
+9.2%
Net income (FY)
$705.1M
Employees
17,000
as of 2026-08-05
Market cap
$18.5B
as of 2026-08-05
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$8.2B$8.2B2025
Net income$705.1M$705.1M2025
Operating income$1.1B$1.1B2025
Total assets$23.1B$23.1B2025
Liabilities$10.4B$10.4B2025
Equity$12.7B$12.7B2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Knees44%
S E T28%
Hips28%
By geography
Americas62%
E M E A22%
Asia Pacific15%
The read
What is Zimmer Biomet Holdings, Inc.’s revenue?
Zimmer Biomet Holdings, Inc. booked $8.2B in FY2025 revenue, growing 7.2% year over year — about the middle of the pack among Healthcare companies we track, at a 8.6% net margin.
Peers · Healthcare
Biogen Inc.85AZoetis Inc.82B+Solventum Corporation65BAgilent Technologies, Inc.85AAvantor, Inc.68BArdent Health Inc.61CKey facts
CEOIvan Tornos
SectorHealthcare
IndustryMedical - Devices
HeadquartersWarsaw, IN
ExchangeNYSE: ZBH
Employees17,000
IPO date2001-07-25
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.